IP Verse

Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates

Patent No. EP3678654 (titled "Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates") was filed by Merck Sharp & Dohme on Sep 4, 2018. The application was issued on Jun 26, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFI PASTEURMar 18, 2025ZWICKER
SK BIOSCIENCEMar 18, 2025ZWICKER
BIOLOGICAL EMar 17, 2025BRAEUNING SCHUBERT PATENTANWALTE GBR

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3678654

MERCK SHARP & DOHME
Application Number
EP18853342A
Filing Date
Sep 4, 2018
Status
Granted And Under Opposition
May 24, 2024
Publication Date
Jun 26, 2024
External Links
Slate, Register , Google Patents